| For: | Cherri S, Libertini M, Zaniboni A. New drugs for the treatment of metastatic colorectal cancer. World J Gastrointest Oncol 2021; 13(11): 1551-1560 [PMID: 34853636 DOI: 10.4251/wjgo.v13.i11.1551] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v13/i11/1551.htm |
| Number | Citing Articles |
| 1 |
Weilong Yao, Longchuan Bai, Shaomeng Wang, Yifan Zhai, Shi-Yong Sun. Mcl-1 levels critically impact the sensitivities of human colorectal cancer cells to APG-1252-M1, a novel Bcl-2/Bcl-XL dual inhibitor that induces Bax-dependent apoptosis. Neoplasia 2022; 29 doi: 10.1016/j.neo.2022.100798
|
| 2 |
Axel Muendlein, Luciano Severgnini, Thomas Decker, Christine Heinzle, Andreas Leiherer, Kathrin Geiger, Heinz Drexel, Thomas Winder, Patrick Reimann, Frank Mayer, Christoph Nonnenbroich, Tobias Dechow. Circulating syndecan-1 and glypican-4 predict 12-month survival in metastatic colorectal cancer patients. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1045995
|
| 3 |
Yusuf Tukur, Abubakar M. Bello, Usman M. Aliyu, Oladapo B. Campbell, Aisha Mustapha, Abubakar Ibrahim Diggi, Yusuf Dantani, Shehu Salihu Umar. RECURRENT RECTAL ADENOCARCINOMA WITH KRAS MUTATION POST-MFOLFOX6/BEVACIZUMAB REMISSION: A CASE REPORT. Nigerian Journal of Oncology 2026; 2(1) doi: 10.67579/njo.2026.1e4nz1ph
|
| 4 |
Robert Kubina, Kamil Krzykawski, Agata Kabała-Dzik, Robert D. Wojtyczka, Ewa Chodurek, Arkadiusz Dziedzic. Fisetin, a Potent Anticancer Flavonol Exhibiting Cytotoxic Activity against Neoplastic Malignant Cells and Cancerous Conditions: A Scoping, Comprehensive Review. Nutrients 2022; 14(13) doi: 10.3390/nu14132604
|